Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Kazmi SH, Naglik JR, Sweet SP, Evans RW, O'Shea S, Banatvala JE, Challacombe SJ.

Clin Vaccine Immunol. 2006 Oct;13(10):1111-8. Epub 2006 Aug 23.

2.

Oral mucosal immunity and HIV infection: current status.

Challacombe SJ, Sweet SP.

Oral Dis. 2002;8 Suppl 2:55-62. Review.

PMID:
12164661
3.

Saliva and inhibition of HIV-1 infection: molecular mechanisms.

Shugars DC, Sweet SP, Malamud D, Kazmi SH, Page-Shafer K, Challacombe SJ.

Oral Dis. 2002;8 Suppl 2:169-75. Review.

PMID:
12164652
4.

Fungal infections associated with HIV infection.

Samaranayake LP, Fidel PL, Naglik JR, Sweet SP, Teanpaisan R, Coogan MM, Blignaut E, Wanzala P.

Oral Dis. 2002;8 Suppl 2:151-60. Review.

PMID:
12164650
5.

Salivary calprotectin levels are raised in patients with oral candidiasis or Sjögren's syndrome but decreased by HIV infection.

Sweet SP, Denbury AN, Challacombe SJ.

Oral Microbiol Immunol. 2001 Apr;16(2):119-23.

PMID:
11240866
6.

Impaired secretory immunity in dystrophic epidermolysis bullosa.

Sweet SP, Ballsdon AE, Harris JC, Roberts GJ, Challacombe SJ.

Oral Microbiol Immunol. 1999 Oct;14(5):316-20.

PMID:
10551159
7.

In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis.

Naglik JR, Newport G, White TC, Fernandes-Naglik LL, Greenspan JS, Greenspan D, Sweet SP, Challacombe SJ, Agabian N.

Infect Immun. 1999 May;67(5):2482-90.

8.

Adherence of Candida albicans to denture-base materials with different surface finishes.

Radford DR, Sweet SP, Challacombe SJ, Walter JD.

J Dent. 1998 Sep;26(7):577-83.

PMID:
9754746
9.

Selection and pathogenicity of Candida albicans in HIV infection.

Sweet SP.

Oral Dis. 1997 May;3 Suppl 1:S88-95. Review. No abstract available.

PMID:
9456665
10.

Salivary and mucosal immune responses to HIV and its co-pathogens.

Challacombe SJ, Sweet SP.

Oral Dis. 1997 May;3 Suppl 1:S79-84. Review.

PMID:
9456663
11.
12.

Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells.

Sweet SP, Cookson S, Challacombe SJ.

J Med Microbiol. 1995 Dec;43(6):452-7.

PMID:
7473680
13.

Serum and saliva immunoglobulin A concentrations show an inverse relationship in HIV infection and AIDS.

Sweet SP, Rahman D, Challacombe SJ.

AIDS. 1995 Nov;9(11):1288-9. No abstract available.

PMID:
8561986
14.

Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection.

Sweet SP, Challacombe SJ, Naglik JR.

Adv Exp Med Biol. 1995;371B:1031-4. No abstract available.

PMID:
7502746
16.

Effect of iron concentration on siderophore synthesis and pigment production by Candida albicans.

Sweet SP, Douglas LJ.

FEMS Microbiol Lett. 1991 May 1;64(1):87-91.

PMID:
1830280
17.

Effect of iron deprivation on surface composition and virulence determinants of Candida albicans.

Sweet SP, Douglas LJ.

J Gen Microbiol. 1991 Apr;137(4):859-65.

PMID:
1856681
18.

An in vitro method to study the adherence of bacteria to saliva-treated tooth enamel sections.

Sweet SP, MacFarlane TW, Samaranayake LP.

Oral Microbiol Immunol. 1990 Feb;5(1):24-8.

PMID:
2087341
19.

An in vitro method to study the adherence of oral bacteria to HeLa cells.

Sweet SP, MacFarlane TW, Samaranayake LP.

Microbios. 1989;60(242):15-22.

PMID:
2607993

Supplemental Content

Loading ...
Support Center